Alnylam Pharmaceuticals
ALNY
#606
Rank
ยฃ26.48 B
Marketcap
ยฃ205.33
Share price
-1.54%
Change (1 day)
52.81%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company